These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells. Hess AD; Thoburn CJ Biol Blood Marrow Transplant; 2006 May; 12(5):518-29. PubMed ID: 16635787 [TBL] [Abstract][Full Text] [Related]
3. Despite efficient intrathymic negative selection of host-reactive T cells, autoimmune disease may develop in porcine thymus-grafted athymic mice: evidence for failure of regulatory mechanisms suppressing autoimmunity. Zhao Y; Rodriguez-Barbosa JI; Shimizu A; Sachs DH; Sykes M Transplantation; 2003 Jun; 75(11):1832-40. PubMed ID: 12811242 [TBL] [Abstract][Full Text] [Related]
4. Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. Sakoda Y; Hashimoto D; Asakura S; Takeuchi K; Harada M; Tanimoto M; Teshima T Blood; 2007 Feb; 109(4):1756-64. PubMed ID: 17032915 [TBL] [Abstract][Full Text] [Related]
5. Differential MHC expression requirements for positive selection of separate TCR Vb families. Brenden N; Böhme J Immunogenetics; 1999 Jan; 49(1):1-6. PubMed ID: 9811963 [TBL] [Abstract][Full Text] [Related]
6. TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice. Brown GR; Lee E; Thiele DL J Immunol; 2002 Mar; 168(6):3065-71. PubMed ID: 11884480 [TBL] [Abstract][Full Text] [Related]
7. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. Drobyski WR; Majewski D; Hanson G Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102 [TBL] [Abstract][Full Text] [Related]
8. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Sakaguchi S; Sakaguchi N; Asano M; Itoh M; Toda M J Immunol; 1995 Aug; 155(3):1151-64. PubMed ID: 7636184 [TBL] [Abstract][Full Text] [Related]
9. Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells. Wu T; Young JS; Johnston H; Ni X; Deng R; Racine J; Wang M; Wang A; Todorov I; Wang J; Zeng D J Immunol; 2013 Jul; 191(1):488-99. PubMed ID: 23709681 [TBL] [Abstract][Full Text] [Related]
10. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning. Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935 [TBL] [Abstract][Full Text] [Related]
11. Self-reactive T cells selected on thymic cortical epithelium are polyclonal and are pathogenic in vivo. Laufer TM; Fan L; Glimcher LH J Immunol; 1999 May; 162(9):5078-84. PubMed ID: 10227976 [TBL] [Abstract][Full Text] [Related]
12. Peripheral T cells re-enter the thymus and interfere with central tolerance induction. Edelmann SL; Marconi P; Brocker T J Immunol; 2011 May; 186(10):5612-9. PubMed ID: 21471449 [TBL] [Abstract][Full Text] [Related]
13. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment. Drobyski WR; Majewski D; Ozker K; Hanson G J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263 [TBL] [Abstract][Full Text] [Related]
14. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Sato K; Yamashita N; Baba M; Matsuyama T Blood; 2003 May; 101(9):3581-9. PubMed ID: 12511411 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of graft-versus-host disease by double-negative regulatory T cells. Young KJ; DuTemple B; Phillips MJ; Zhang L J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991 [TBL] [Abstract][Full Text] [Related]
16. MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice. Wu L; Li N; Zhang M; Xue SL; Cassady K; Lin Q; Riggs AD; Zeng D Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15994-9. PubMed ID: 26647186 [TBL] [Abstract][Full Text] [Related]
17. A role for accessibility to self-peptide-self-MHC complexes in intrathymic negative selection. Viret C; Sant'Angelo DB; He X; Ramaswamy H; Janeway CA J Immunol; 2001 Apr; 166(7):4429-37. PubMed ID: 11254698 [TBL] [Abstract][Full Text] [Related]
18. Analyses of acute graft-versus-host-like reaction in [MRL/lpr----MRL/+] chimeric mice using MRL/lpr-Thy-1. 1 congenic mice. Nakagawa T; Nagata N; Hosaka N; Inaba M; Yasumizu R; Ogawa R; Ikehara S Cell Immunol; 1991 Oct; 137(1):189-99. PubMed ID: 1679378 [TBL] [Abstract][Full Text] [Related]
19. Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome. Blazar BR; Taylor PA; Snover DC; Sehgal SN; Vallera DA J Immunol; 1993 Nov; 151(10):5726-41. PubMed ID: 8228258 [TBL] [Abstract][Full Text] [Related]
20. [CD4+, CD25+ regulatory T-lymphocytes: current concepts and therapeutic potential]. Salomon B J Soc Biol; 2002; 196(4):263-6. PubMed ID: 12645292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]